John Cox
CEO & President, Director at Dyne Therapeutics, Inc. (DYN) since March 2024
John Cox has filed 30 insider reports with the SEC since June 2021, as CEO & President and director at Dyne Therapeutics, Inc. (DYN) and director at Sigilon Therapeutics, Inc. (SGTX). In the last 12 months John Cox sold $536K of stock on the open market. On November 13, 2026 John Cox filed a Form 144 notice and plans to sell 5,513 DYN shares (~$92.8K). In the latest filing, on November 16, 2026, John Cox sold 5,513 shares of Dyne Therapeutics, Inc. (DYN) for $92.7K at an average of $16.82.
Planned sale (Form 144)
- John Cox plans to sell 5,513 DYN shares (~$92.8K), around Nov 13, 2026. Notice filed Nov 13, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 30
- Companies
- 2
- Bought on market
- $1.97M
- Sold on market
- $674K
Companies where John Cox is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| CEO & President, Directorsince March 2024 | 351,994 | $1.97M | $674K | $14.91 | $15.50+4.0% | Nov 16, 2026 | |
| Director | 0 | Aug 11, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 13, 2026-$92.7KDYNCEO & President Cox John sold $92,729 worth of shares (5,513 units at $16.82) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 351,994 units (withholding tax)Form 4Open-market sale10b5-1 plan
- Nov 13, 2026~$92.8KDYNJohn Cox plans to sell 5,513 shares (~$92.8K)Form 144Planned sale
- Sep 8, 2026~$107KDYNJohn Cox plans to sell 5,658 shares (~$107K)Form 144Planned sale
- Sep 8, 2026-$107KDYNCEO & President Cox John sold $106,823 worth of shares (5,658 units at $18.88) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 357,507 units (tax withholding)Form 4Open-market sale10b5-1 plan
- Aug 13, 2026-$131KDYNCEO & President Cox John sold $131,032 worth of shares (4,986 units at $26.28) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 363,165 units to satisfy withholding taxForm 4Open-market sale10b5-1 plan
- Aug 13, 2026~$131KDYNJohn Cox plans to sell 4,986 shares (~$131K)Form 144Planned sale
- Jun 16, 2026-$49.2KDYNCEO & President Cox John sold $49,179 worth of shares (2,683 units at $18.33) as part of a pre-agreed trading plan, decreasing direct ownership by 0.72% to 368,151 units to satisfy tax liabilityForm 4Open-market sale10b5-1 plan
- Jun 16, 2026~$49.2KDYNJohn Cox plans to sell 2,683 shares (~$49.2K)Form 144Planned sale
- May 13, 2026-$60.8KDYNCEO & President Cox John sold $60,790 worth of shares (3,311 units at $18.36) as part of a pre-agreed trading plan, decreasing direct ownership by 0.88% to 370,834 units (withholding obligation)Form 4Open-market sale10b5-1 plan
- May 13, 2026~$60.8KDYNJohn Cox plans to sell 3,311 shares (~$60.8K)Form 144Planned sale
- Mar 5, 2026-$40.7KDYNCEO & President Cox John sold $40,707 worth of shares (2,732 units at $14.90), decreasing direct ownership by 0.72% to 374,145 unitsForm 4Open-market sale10b5-1 plan
- Mar 5, 2026~$40.7KDYNJohn Cox plans to sell 2,732 shares (~$40.7K)Form 144Planned sale
- Feb 12, 2026DYNCEO & President Cox John was granted 180,000 shares, increasing direct ownership by 91% to 376,877 unitsForm 4Grant or award
- Dec 5, 2025~$55.2KDYNJohn Cox plans to sell 2,662 shares (~$55.2K)Form 144Planned sale
- Dec 5, 2025-$55.2KDYNCEO & President Cox John sold $55,157 worth of shares (2,662 units at $20.72), decreasing direct ownership by 1% to 196,877 unitsForm 4Open-market sale10b5-1 plan
- Sep 5, 2025-$35.4KDYNCEO & President Cox John sold $35,402 worth of shares (2,640 units at $13.41), decreasing direct ownership by 1% to 199,539 unitsForm 4Open-market sale10b5-1 plan
- Sep 5, 2025~$35.4KDYNJohn Cox plans to sell 2,640 shares (~$35.4K)Form 144Planned sale
- Jul 16, 2025DYNSEC Form 4 filed by CEO & President Cox JohnForm 4Grant or award
- Jul 15, 2025+$911KDYNCEO & President Cox John gifted 40,000 shares and bought $911,000 worth of shares (100,000 units at $9.11), increasing direct ownership by 42% to 202,179 unitsForm 4GiftOpen-market purchase
- Jun 5, 2025-$54.2KDYNCEO & President Cox John sold $54,201 worth of shares (4,060 units at $13.35), decreasing direct ownership by 3% to 142,179 unitsForm 4Open-market sale10b5-1 plan
- Jun 5, 2025~$54.2KDYNJohn Cox plans to sell 4,060 shares (~$54.2K)Form 144Planned sale
- Mar 5, 2025-$48KDYNCEO & President Cox John sold $48,042 worth of shares (4,061 units at $11.83), decreasing direct ownership by 3% to 146,239 unitsForm 4Open-market sale10b5-1 plan
- Mar 5, 2025~$48.4KDYNJohn Cox plans to sell 4,067 shares (~$48.4K)Form 144Planned sale
- Dec 4, 2024DYNCEO & President Cox John was granted 145,300 shares, increasing direct ownership by 2,906% to 150,300 unitsForm 4Grant or award
- Sep 4, 2024+$1.06MDYNCEO & President Cox John bought $1,057,216 worth of shares (32,000 units at $33.04)Form 4Open-market purchase
- Mar 25, 2024DYNNew insider Cox John claimed ownership of 5,000 shares (Amendment)Form 3New insider
- Mar 25, 2024DYNNew insider Cox John claimed ownership of 10,000 sharesForm 3New insider
- Aug 11, 2023SGTXSEC Form 4: Cox John returned 341 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- May 19, 2023SGTXSEC Form 4 filed by Cox JohnForm 4Grant or award
- Jun 24, 2021SGTXSEC Form 4 filed by Cox JohnForm 4Grant or award
Compare John Cox with
- John Cox vs Johanna Friedl-Naderer1 shared
- John Cox vs Douglas Kerr1 shared
- John Cox vs Erick Lucera1 shared
- John Cox vs Jason P Rhodes1 shared
- John Cox vs Dirk Kersten1 shared
- John Cox vs Barry E Greene1 shared
Other insiders at the same companies
- Johanna Friedl-NadererDYN
- Douglas KerrDYN
- Erick LuceraDYN
- Jason P RhodesDYN
- Atlas Venture Opportunity Fund I, L.P.DYN
- Atlas Venture Fund XI, L.P.DYN
- Dirk KerstenDYN
- Atlas Venture Associates Xi, L.P.DYN
- Barry E GreeneDYN
- Edward HurwitzDYN
- David Charles LubnerDYN
- Carlo IncertiDYN
- Catherine Stehman-BreenDYN
- Brian S PosnerDYN
- Atlas Venture Opportunity Fund II, L.P.DYN
- Vikram KarnaniDYN
Questions about John Cox
- What is John Cox's role at Dyne Therapeutics, Inc.?
- John Cox reports to the SEC as CEO & President and director at Dyne Therapeutics, Inc. (DYN), according to the latest filing on November 16, 2026. John Cox has also filed as director at Sigilon Therapeutics, Inc. (SGTX).
- How many shares does John Cox own?
- After the latest filing that states it, John Cox directly owned 351,994 shares of Dyne Therapeutics, Inc. (DYN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has John Cox bought or sold stock recently?
- The most recent open-market purchase was on July 15, 2025: bought 100,000 shares of Dyne Therapeutics, Inc. (DYN) for $911K at an average of $9.11. The most recent open-market sale was on November 13, 2026: sold 5,513 shares of Dyne Therapeutics, Inc. (DYN) for $92.7K at an average of $16.82.
- How do I get alerts when John Cox files?
- Follow John Cox on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. John Cox filed 4 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by John Cox (SEC CIK 0001498428). Totals count each trade once, skipping amendments whose original is on file, from Jun 28, 2021 on. View on SEC EDGAR · Get this as JSON